Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trials

Background & objectives: Type 2 diabetes mellitus (T2DM) is a pressing public health concern, contributing to 11 % of annual deaths and incurring direct expenses of $760 billion. Studies show intermittent fasting (IF) can effectively lower glycated haemoglobin (HbA1c) levels and reduce weigh...

Full description

Saved in:
Bibliographic Details
Main Authors: Joshua Chadwick, Lavanya Ayyasamy, Madhanraj Kalyanasundaram, Ganeshkumar Parasuraman, Bhavani Shankara Bagepally, Jeyashree Kathiresan, Lokesh Shanmugam
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Diabetes Epidemiology and Management
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666970624000532
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586226912198656
author Joshua Chadwick
Lavanya Ayyasamy
Madhanraj Kalyanasundaram
Ganeshkumar Parasuraman
Bhavani Shankara Bagepally
Jeyashree Kathiresan
Lokesh Shanmugam
author_facet Joshua Chadwick
Lavanya Ayyasamy
Madhanraj Kalyanasundaram
Ganeshkumar Parasuraman
Bhavani Shankara Bagepally
Jeyashree Kathiresan
Lokesh Shanmugam
author_sort Joshua Chadwick
collection DOAJ
description Background & objectives: Type 2 diabetes mellitus (T2DM) is a pressing public health concern, contributing to 11 % of annual deaths and incurring direct expenses of $760 billion. Studies show intermittent fasting (IF) can effectively lower glycated haemoglobin (HbA1c) levels and reduce weight and levels in individuals with type 2 diabetes. The study's objective is to evaluate the efficacy and safety of IF on glycaemic control among patients with T2DM. Methods: We conducted searches in the MEDLINE (Ovid), Embase, and SINOMED databases until February 29, 2024, focusing on glycaemic control as the outcome of interest. Secondary outcomes included changes in weight, and BMI (PROSPERO ID: CRD42022357598). We used a random effect model to synthesize the effect measure. We performed a sensitivity analysis to assess the robustness of the result. Results: Out of the 24 studies identified, nine were deemed suitable for inclusion. Four studies, including 238 participants, were selected for the meta-analysis. The analysis revealed that IF and regular diets showed similar effects on glycemic control, HbA1c (−1.27 %, 95 % confidence interval [CI] −3.71 to 1.17) and fasting plasma glucose (−1.66, 95 % CI −4.22 to 0.90). Weight reduction outcomes were also similar between the two diets (−0.26, 95 % CI −1.43 to 0.91 kg). The frequency of hypoglycemic episodes was comparable across both groups. Interpretation & conclusions: On the basis of moderate to low certainty of evidence, IF can be a safe dietary approach for patients with T2DM, with similar safety and effectiveness profiles to regular diets. However, larger-scale studies are recommended to confirm these findings.
format Article
id doaj-art-cff6f89025ff4ffb921e54c711b3b2b0
institution Kabale University
issn 2666-9706
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Diabetes Epidemiology and Management
spelling doaj-art-cff6f89025ff4ffb921e54c711b3b2b02025-01-26T05:05:12ZengElsevierDiabetes Epidemiology and Management2666-97062025-01-0117100249Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trialsJoshua Chadwick0Lavanya Ayyasamy1Madhanraj Kalyanasundaram2Ganeshkumar Parasuraman3Bhavani Shankara Bagepally4Jeyashree Kathiresan5Lokesh Shanmugam6Corresponding author.; ICMR-National Institute of Epidemiology, Department of Health Research, Ministry of Health and Family Welfare, Govt. of India, Chennai, Tamil Nadu, IndiaICMR-National Institute of Epidemiology, Department of Health Research, Ministry of Health and Family Welfare, Govt. of India, Chennai, Tamil Nadu, IndiaICMR-National Institute of Epidemiology, Department of Health Research, Ministry of Health and Family Welfare, Govt. of India, Chennai, Tamil Nadu, IndiaICMR-National Institute of Epidemiology, Department of Health Research, Ministry of Health and Family Welfare, Govt. of India, Chennai, Tamil Nadu, IndiaICMR-National Institute of Epidemiology, Department of Health Research, Ministry of Health and Family Welfare, Govt. of India, Chennai, Tamil Nadu, IndiaICMR-National Institute of Epidemiology, Department of Health Research, Ministry of Health and Family Welfare, Govt. of India, Chennai, Tamil Nadu, IndiaICMR-National Institute of Epidemiology, Department of Health Research, Ministry of Health and Family Welfare, Govt. of India, Chennai, Tamil Nadu, IndiaBackground & objectives: Type 2 diabetes mellitus (T2DM) is a pressing public health concern, contributing to 11 % of annual deaths and incurring direct expenses of $760 billion. Studies show intermittent fasting (IF) can effectively lower glycated haemoglobin (HbA1c) levels and reduce weight and levels in individuals with type 2 diabetes. The study's objective is to evaluate the efficacy and safety of IF on glycaemic control among patients with T2DM. Methods: We conducted searches in the MEDLINE (Ovid), Embase, and SINOMED databases until February 29, 2024, focusing on glycaemic control as the outcome of interest. Secondary outcomes included changes in weight, and BMI (PROSPERO ID: CRD42022357598). We used a random effect model to synthesize the effect measure. We performed a sensitivity analysis to assess the robustness of the result. Results: Out of the 24 studies identified, nine were deemed suitable for inclusion. Four studies, including 238 participants, were selected for the meta-analysis. The analysis revealed that IF and regular diets showed similar effects on glycemic control, HbA1c (−1.27 %, 95 % confidence interval [CI] −3.71 to 1.17) and fasting plasma glucose (−1.66, 95 % CI −4.22 to 0.90). Weight reduction outcomes were also similar between the two diets (−0.26, 95 % CI −1.43 to 0.91 kg). The frequency of hypoglycemic episodes was comparable across both groups. Interpretation & conclusions: On the basis of moderate to low certainty of evidence, IF can be a safe dietary approach for patients with T2DM, with similar safety and effectiveness profiles to regular diets. However, larger-scale studies are recommended to confirm these findings.http://www.sciencedirect.com/science/article/pii/S2666970624000532Intermittent fastingDiabetes mellitusRandomized clinical trialSystematic review and meta-analysisSafety and efficacy
spellingShingle Joshua Chadwick
Lavanya Ayyasamy
Madhanraj Kalyanasundaram
Ganeshkumar Parasuraman
Bhavani Shankara Bagepally
Jeyashree Kathiresan
Lokesh Shanmugam
Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trials
Diabetes Epidemiology and Management
Intermittent fasting
Diabetes mellitus
Randomized clinical trial
Systematic review and meta-analysis
Safety and efficacy
title Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trials
title_full Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trials
title_fullStr Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trials
title_full_unstemmed Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trials
title_short Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trials
title_sort efficacy and safety of intermittent fasting for type 2 diabetes mellitus a systematic review and meta analysis of randomized trials
topic Intermittent fasting
Diabetes mellitus
Randomized clinical trial
Systematic review and meta-analysis
Safety and efficacy
url http://www.sciencedirect.com/science/article/pii/S2666970624000532
work_keys_str_mv AT joshuachadwick efficacyandsafetyofintermittentfastingfortype2diabetesmellitusasystematicreviewandmetaanalysisofrandomizedtrials
AT lavanyaayyasamy efficacyandsafetyofintermittentfastingfortype2diabetesmellitusasystematicreviewandmetaanalysisofrandomizedtrials
AT madhanrajkalyanasundaram efficacyandsafetyofintermittentfastingfortype2diabetesmellitusasystematicreviewandmetaanalysisofrandomizedtrials
AT ganeshkumarparasuraman efficacyandsafetyofintermittentfastingfortype2diabetesmellitusasystematicreviewandmetaanalysisofrandomizedtrials
AT bhavanishankarabagepally efficacyandsafetyofintermittentfastingfortype2diabetesmellitusasystematicreviewandmetaanalysisofrandomizedtrials
AT jeyashreekathiresan efficacyandsafetyofintermittentfastingfortype2diabetesmellitusasystematicreviewandmetaanalysisofrandomizedtrials
AT lokeshshanmugam efficacyandsafetyofintermittentfastingfortype2diabetesmellitusasystematicreviewandmetaanalysisofrandomizedtrials